| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,209,917 | 1,203,155 | 1,656,848 | 1,203,121 | | Cost of Revenue | 684,184 | 808,501 | 745,713 | 788,910 | | | Gross Profit | 525,733 | 394,654 | 911,135 | 414,211 | | | Operating Expenses | | Research Development | 58,836 | 77,897 | 74,721 | 80,755 | | Selling General and Administrative | 239,556 | 265,532 | 275,584 | 259,456 | | Non Recurring |
-
| 16,634 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 227,341 | 34,591 | 560,830 | 74,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,189 | (9,246) | 5,767 | 7,855 | | Earnings Before Interest And Taxes | 231,530 | 25,345 | 566,597 | 81,855 | | Interest Expense | 85,002 | 92,256 | 87,553 | 86,489 | | Income Before Tax | 146,528 | (66,911) | 479,044 | (4,634) | | Income Tax Expense | 37,454 | (59,955) | 272,438 | (30,955) | | Minority Interest |
-
| 1,765 | 152 | 72 | | | | Net Income From Continuing Ops | 109,074 | (5,191) | 206,758 | 26,393 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 109,074 | (5,191) | 206,758 | 26,393 | | Preferred Stock And Other Adjustments | (37,775) | (34,799) | (34,759) | (34,759) | | | Net Income Applicable To Common Shares | $71,299 | ($39,990) | $171,999 | ($8,366) |
|
0.45% Nasdaq 
0.20%
Income Statement
